Advertisement
Screener

CRONOS GROUP INC. (CRON) Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31)

2.2 / 5 stars · 30/68 Roast Me

CRONOS GROUP INC. Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31)

CRONOS GROUP INC. (CRON) reported Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) of $52.00 thousand for the 12-month period ending 2019-12-31, per its 10-K/A filed 2020-03-30.

Discontinued › Income Statement › Other Income

us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue · last filed 2020-03-30

  • CRONOS GROUP INC. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2019 was $52.00K, a 99.03% decline from fiscal 2018.
  • CRONOS GROUP INC. equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2018 was $5.34M.
Period endEquity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 12 month
2019-12-31$52.00K
10-K/A · filed 2020-03-30
2018-12-31$5.34M
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87